EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Primary CNS Vasculitis - A Focussed Review on Treatment

Praveen Kesav iD, Divya Manesh Raj, Rula A Hajj-Ali, Syed I Hussain iD, Seby John iD

Vascular Health and Risk Management · 2024-10 · Volume 20 · 453-465

DOI: 10.2147/vhrm.s488202 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Vascular Health and Risk Management, 2024-10. Verfasst von Praveen Kesav und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Vasculitis, Central Nervous System. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary central nervous system vasculitis (PCNSV) is a rare and complex disease that poses formidable diagnostic and therapeutic challenges. Since its initial recognition as a distinct clinical entity in the 1950s, there has been considerable advancement in our understanding of PCNSV histopathology, specific clinical subsets, and their response to treatment. However, PCNSV is one of the rarest vasculitides, and still remains a challenging diagnosis with many unanswered questions regarding optimal management. In this review, we intend to provide a detailed outline of approaches that are currently being employed for the treatment of PCNSV. We exhaustively review available cohort series of PCNSV and critically appraise the data for study definitions, treatment approaches, and predictors of treatment outcomes. Finally, we also propose a treatment approach for PCNSV.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vasculitis, Central Nervous SystemHumansTreatment OutcomeRisk FactorsImmunosuppressive AgentsMaleFemaleAdult

Stichwörter der Autor:innen

PACNSPCNSVinductionmaintenanceoutcomesprimary CNS vasculitisprimary angiitis of CNSrelapseremissiontreatment

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Department of Neurology, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Research Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.
  • Department of Rheumatic and Immunologic Diseases, Center for Vasculitis Care and Research, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
  • Department of Neuro-Interventional Surgery, Neurological Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

ORCID-Profile: Praveen Kesav, Syed I Hussain, Seby John

Zitieren

APA

Kesav, P., Raj, D. M., Hajj-Ali, R. A., Hussain, S. I., & John, S. (2024). Primary CNS Vasculitis - A Focussed Review on Treatment. Vascular Health and Risk Management, Volume 20, 453-465. https://doi.org/10.2147/vhrm.s488202

Vancouver

Kesav P, Raj DM, Hajj-Ali RA, Hussain SI, John S. Primary CNS Vasculitis - A Focussed Review on Treatment. Vascular Health and Risk Management. 2024;Volume 20:453-465. doi:10.2147/vhrm.s488202

BibTeX
@article{Kesav2024,
  author = {Kesav, Praveen and Raj, Divya Manesh and Hajj-Ali, Rula A and Hussain, Syed I and John, Seby},
  title = {Primary CNS Vasculitis - A Focussed Review on Treatment},
  journal = {Vascular Health and Risk Management},
  year = {2024},
  volume = {Volume 20},
  pages = {453--465},
  doi = {10.2147/vhrm.s488202}
}
Kostenlos starten →